Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.68 USD
−381.64 M USD
0.00 USD
72.66 M
About ACELYRIN, INC.
Sector
CEO
Mina Kim
Headquarters
Agoura Hills
Website
Founded
2020
FIGI
BBG00YJKJ8H4
ACELYRIN, Inc. operates as a biopharma company. It engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company was founded by Shao-Lee Lin on July 27, 2020 and is headquartered in Agoura Hills, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SLRN is 4.70 USD — it has increased by 8.55% in the past 24 hours. Watch ACELYRIN, INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ACELYRIN, INC. stocks are traded under the ticker SLRN.
SLRN stock has fallen by −9.44% compared to the previous week, the month change is a −24.92% fall, over the last year ACELYRIN, INC. has showed a −45.73% decrease.
We've gathered analysts' opinions on ACELYRIN, INC. future price: according to them, SLRN price has a max estimate of 20.00 USD and a min estimate of 6.00 USD. Watch SLRN chart and read a more detailed ACELYRIN, INC. stock forecast: see what analysts think of ACELYRIN, INC. and suggest that you do with its stocks.
SLRN reached its all-time high on Aug 23, 2023 with the price of 29.88 USD, and its all-time low was 3.36 USD and was reached on Aug 14, 2024. View more price dynamics on SLRN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SLRN stock is 10.96% volatile and has beta coefficient of 1.41. Track ACELYRIN, INC. stock price on the chart and check out the list of the most volatile stocks — is ACELYRIN, INC. there?
Today ACELYRIN, INC. has the market capitalization of 469.10 M, it has decreased by −7.68% over the last week.
Yes, you can track ACELYRIN, INC. financials in yearly and quarterly reports right on TradingView.
ACELYRIN, INC. is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
SLRN earnings for the last quarter are −0.49 USD per share, whereas the estimation was −0.80 USD resulting in a 38.65% surprise. The estimated earnings for the next quarter are −0.85 USD per share. See more details about ACELYRIN, INC. earnings.
ACELYRIN, INC. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
SLRN net income for the last quarter is −48.55 M USD, while the quarter before that showed −85.67 M USD of net income which accounts for 43.33% change. Track more ACELYRIN, INC. financial stats to get the full picture.
No, SLRN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 130.00 employees. See our rating of the largest employees — is ACELYRIN, INC. on this list?
Like other stocks, SLRN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACELYRIN, INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ACELYRIN, INC. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ACELYRIN, INC. stock shows the sell signal. See more of ACELYRIN, INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.